EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $563,000 | -23.4% | 12,100 | -30.1% | 0.00% | -20.0% |
| Q3 2020 | $735,000 | -55.5% | 17,300 | -49.7% | 0.01% | -61.5% |
| Q2 2020 | $1,651,000 | +7.1% | 34,400 | +2.7% | 0.01% | +62.5% |
| Q1 2020 | $1,541,000 | -25.2% | 33,500 | -2.3% | 0.01% | -50.0% |
| Q4 2019 | $2,061,000 | +7.2% | 34,300 | +0.9% | 0.02% | 0.0% |
| Q3 2019 | $1,923,000 | -12.6% | 34,000 | -13.9% | 0.02% | -15.8% |
| Q2 2019 | $2,199,000 | -22.2% | 39,500 | -29.5% | 0.02% | -26.9% |
| Q1 2019 | $2,827,000 | +34.2% | 56,000 | +7.1% | 0.03% | +36.8% |
| Q4 2018 | $2,107,000 | -31.9% | 52,300 | +17.3% | 0.02% | -17.4% |
| Q3 2018 | $3,092,000 | – | 44,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |